About this document "ctDNA MRD assay (Signatera™)": How much does ctDNA MRD assay (Signatera™) typically cost

Based on the document content, the ctDNA MRD assay (Signatera™) costs $1000+. However, it's important to note two key points from the document:

1. Insurance Coverage: The test is currently listed as "No (investigational)" for insurance coverage, meaning patients would likely need to pay out-of-pocket.

2. Clinical Trial Status: According to the document, this test is currently for "Stage II-III post-op (clinical trial use)."

For context on testing costs and coverage, I should note that:

According to NCCN Guidelines for Colorectal Cancer (2023), while circulating tumor DNA (ctDNA) testing shows promise for monitoring molecular residual disease, it is still considered investigational. The guidelines recommend that such testing should ideally be conducted within the context of a clinical trial.

The American Society of Clinical Oncology (ASCO) guidelines similarly note that while ctDNA testing is an emerging technology for monitoring colorectal cancer, standards for coverage and reimbursement are still evolving.

I would recommend:

1. Discussing with your healthcare provider about whether this test is appropriate for your situation
2. Checking with both the testing company and your insurance provider about any potential coverage or payment plans
3. Inquiring about whether there are any active clinical trials in your area that might cover the cost of testing